Questions? Call 888-624-8373

PAPERBACK
list:$49.00
Web:$44.10
add to cart

PDF BOOK
your price: $37.50
add to cart

Rights & Permissions

topleft topright

Issues in Risk Assessment (1993)
Commission on Life Sciences (CLS)

Page
93
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Issues in Risk Assessment

Appendix C
Federal Liaison Group

Dr. Deborah Barsotti

Agency for Toxic Substances and Disease Registry

Atlanta, GA

Dr. James Beall

U.S. Department of Energy

Washington, DC

Dr. William Cibulas

Agency for Toxic Substances and Disease Registry

Atlanta, GA

Dr. Murray S. Cohn

Consumer Product Safety Commission

Bethesda, MD

Dr. Joseph Cotruvo

U.S. Environmental Protection Agency

Washington, DC

Dr. William H. Farland

U.S. Environmental Protection Agency

Washington, DC

Dr. Herman Gibb

U.S. Environmental Protection Agency

Washington, DC

Dr. Walter H. Glinsmann

U.S. Food and Drug Administration

Washington, DC

Dr. Bryan D. Hardin

National Institute for Occupational Safety and Health

Cincinnati, OH

Dr. Peter Infante

U.S. Department of Labor/OSHA

Washington, DC

Page
93
Front Matter (R1-R18)
Executive Summary (1-12)
Use of the Maximum Tolerated Dose in Animal Bioassays for Carcinogenicity (13-14)
1 Introduction (15-20)
2 Correlations Between Carcinogenic Potency and Other Measures of Toxicity (21-42)
3 Advantages and Disadvantages of Bioassys That Use the MTD (43-52)
4 Options Considered (53-60)
5 Conclusions and Recommendations (61-66)
References (67-78)
Appendix A: Workshop Summary - Maximum Tolerated Dose: Implications for Risk Assessment (79-90)
Appendix B: Workshop Organizing Subcommittee (91-92)
Appendix C: Workshop Federal Liaison Group (93-94)
Appendix D: Workshop Programs (95-96)
Appendix E: Workshop Attendees (97-110)
Appendix F: Correlation Between Carcinogenic Potency and the Maximum Tolerated Dose: Implications for Risk Assessment (111-172)
Appendix G: Informal Search for Supercarcinogens (173-184)
The Two-Stage Model of Carcinogenesis (185-186)
Issues in Risk Assessment (187-216)
References (217-222)
Appendix A: Workshop Summary - Two-Stage Modelsof Carcinogenesis (223-232)
Appendix B: Workshop Program (233-234)
Appendix C: Workshop Federal Liaison Group (235-236)
Appendix D: Workshop Attendees (237-238)
Appendix E: Workshop Organizing Task Group (239-240)
A Paradigm for Ecological Risk Assessment (241-242)
1 Introduction (243-246)
2 Scope of Ecological Risk Assessment (247-248)
3 Revision of 1983 Framework to Incorporate Ecological Risk Assessment (249-258)
4 Key Scientific Problems Limiting Application of Ecological Risk Assessment (259-264)
5 Conclusions (265-266)
6 Recommendations (267-268)
References (269-272)
Appendix A: Workshop Participants (273-278)
Appendix B: Workshop Organizing Subcommittee and Federal Liaison Group (279-280)
Appendix C: Workshop Introduction (281-282)
Appendix D: Opening Plenary Presentations (283-292)
Appendix E: Case Studies and Commentaries (293-308)
Appendix F: Breakout Sessions (309-336)
Appendix G: Contemplations on Ecological Risk Assessment (337-342)
Appendix H: Workshop Summary (343-346)
Appendix I: References for Appendixes (347-350)
Appendix J: Workshop Program (351-356)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 93
Issues in Risk Assessment Appendix C Federal Liaison Group Dr. Deborah Barsotti Agency for Toxic Substances and Disease Registry Atlanta, GA Dr. James Beall U.S. Department of Energy Washington, DC Dr. William Cibulas Agency for Toxic Substances and Disease Registry Atlanta, GA Dr. Murray S. Cohn Consumer Product Safety Commission Bethesda, MD Dr. Joseph Cotruvo U.S. Environmental Protection Agency Washington, DC Dr. William H. Farland U.S. Environmental Protection Agency Washington, DC Dr. Herman Gibb U.S. Environmental Protection Agency Washington, DC Dr. Walter H. Glinsmann U.S. Food and Drug Administration Washington, DC Dr. Bryan D. Hardin National Institute for Occupational Safety and Health Cincinnati, OH Dr. Peter Infante U.S. Department of Labor/OSHA Washington, DC

OCR for page 94
Issues in Risk Assessment Dr. Ronald J. Lorentzen U.S. Food and Drug Administration Washington, DC Dr. Edward Ohanian U.S. Environmental Protection Agency Washington, DC Mr. Richard Orr U.S. Department of Agriculture Hyattville, MD Dr. Richard Parry, Jr. U.S. Department of Agriculture Beltsville, MD Dr. Dorothy Patton U.S. Environmental Protection Agency Washington, DC Dr. Peter Preuss U.S. Environmental Protection Agency Washington, DC Dr. Lorenz R. Rhomberg U.S. Environmental Protection Agency Washington, DC Dr. Matthew H. Royer U.S. Department of Agriculture Hyattsville, MD Dr. Lilly Sanathanan U.S. Food and Drug Administration Rockville, MD Dr. Robert Scheuplein U.S. Food and Drug Administration Washington, DC Ms. Janet A. Springer U.S. Food and Drug Administration Washington, DC Dr. Bruce V. Stadel U.S. Food and Drug Administration Rockville, MD Dr. Leslie T. Stayner National Institute for Occupational Safety and Health Cincinnati, OH Mr. Michael T. Werner, JD U.S. Department of Agriculture Hyattsville, MD

Representative terms from entire chapter:

gibb peter